EVX Ventures is a global venture capital firm established in 2015 and headquartered in Singapore. The firm focuses on building, incubating, and investing in early-stage biotechnology companies. It specializes in disruptive therapeutic platform technologies and novel therapeutic modalities, aiming to redefine future therapeutics. By investing in innovative global technologies, EVX Ventures seeks to advance the biotech industry and foster the development of transformative healthcare solutions.
Nuevocor is a preclinical-stage biopharmaceutical company dedicated to the development of gene therapy-based treatments aimed at restoring cardiac function in patients with cardiovascular diseases. The company's research focuses on genetic cardiomyopathies that involve abnormal mechanobiology. By modulating mechanical force transduction, Nuevocor's innovative approaches seek to address the underlying mechanisms of these diseases, ultimately enabling healthcare providers to improve cardiac function in affected individuals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.